InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: MedResCollab post# 200977

Wednesday, 07/10/2019 9:51:27 PM

Wednesday, July 10, 2019 9:51:27 PM

Post# of 429037
M- As you know also the review includes a continuous communication between the FDA and Amarin … and JT know 28th by 25 of June.

Yes, everything is possible ... maybe the FDA has to interview the 8,000+ patients in the R-IT tö avoid the possibility that the data was created by Amarin only …

Best,
G

"There are some things money can't buy. For everything else, there's AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News